Total and Hidden Blood Loss in Biportal Endoscopic Versus Tubular-Based Minimally Invasive Transforaminal Lumbar Interbody Fusion
Clinics in Orthopedic Surgery · 2026
DOI: 10.4055/cios25409 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinics in Orthopedic Surgery, 2026. Verfasst von Tae Hoon Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Blood Loss, Surgical, Spinal Fusion, Lumbar Vertebrae, Endoscopy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of SMEs and Startups.
Abstract (Originalsprache)
Background
The purpose of this study was to compare total blood loss (TBL) and hidden blood loss (HBL) between biportal endoscopic transforaminal lumbar interbody fusion (BE-TLIF) and tubular-based minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) using hematocrit-based calculations. The study aimed to compare blood loss outcomes between the 2 techniques during their respective initial adoption phases to ensure a fair comparison of hemostatic control.
Methods
This retrospective study included 72 patients who underwent single-level lumbar fusion. Thirty-six consecutive BE-TLIF cases (June 2023-July 2025) were compared with 36 early-period MIS-TLIF cases (2016-2021) to ensure comparable learning curve stages. TBL was calculated using Nadler's and Gross's formulas based on hematocrit changes. HBL was derived by subtracting estimated blood loss and drainage from TBL.
Results
The BE-TLIF group underwent more additional adjacent-level decompression procedures and longer operative times than the MIS-TLIF group. However, the BE-TLIF group showed consistently lower TBL at the immediate postoperative time point (0.42 vs. 0.62 L, p = 0.001) and at the time point of maximum calculated loss (0.87 vs. 1.05 L, p = 0.025). HBL was similar between the groups (0.32 vs. 0.43 L, p = 0.262), suggesting that reduced TBL in the BE-TLIF group resulted from decreased intraoperative bleeding rather than postoperative extravasation differences. No patients in either group required blood transfusion.
Conclusions
Despite longer operative times and more extensive adjacent-level decompression procedures, BE-TLIF resulted in significantly lower TBL. HBL was comparable between the techniques, indicating that BE-TLIF's hemostatic advantages are achieved through improved intraoperative control. Even during the initial adoption phase, BE-TLIF demonstrated superior hemostatic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, Korea.
- Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul, Korea.
- Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Department of Anesthesiology and Pain Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea.
ORCID-Profile: Tae Hoon Kang, Byungjun Kang, Jung-Man Lee, Minjoon Cho, Jae Hyup Lee
Förderung
- Ministry of SMEs and Startups
Zitieren
APA
Kang, T. H., Kang, B., Lee, J. M., Cho, M., & Lee, J. H. (2026). Total and Hidden Blood Loss in Biportal Endoscopic Versus Tubular-Based Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clinics in Orthopedic Surgery. https://doi.org/10.4055/cios25409
Vancouver
Kang TH, Kang B, Lee JM, Cho M, Lee JH. Total and Hidden Blood Loss in Biportal Endoscopic Versus Tubular-Based Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clinics in Orthopedic Surgery. 2026. doi:10.4055/cios25409
BibTeX
@article{Kang2026,
author = {Kang, Tae Hoon and Kang, Byungjun and Lee, Jung-Man and Cho, Minjoon and Lee, Jae Hyup},
title = {Total and Hidden Blood Loss in Biportal Endoscopic Versus Tubular-Based Minimally Invasive Transforaminal Lumbar Interbody Fusion},
journal = {Clinics in Orthopedic Surgery},
year = {2026},
doi = {10.4055/cios25409}
}
EUVIMED